| Key Financial Ratios of Glenmark Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
48.00 |
57.49 |
35.95 |
75.86 |
52.87 |
|
| Diluted EPS (Rs.) |
48.00 |
57.49 |
35.94 |
75.84 |
52.86 |
|
| Cash EPS (Rs.) |
52.91 |
61.25 |
40.14 |
79.58 |
56.14 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
468.73 |
423.22 |
368.27 |
334.43 |
261.06 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
468.73 |
423.22 |
368.27 |
334.43 |
261.06 |
|
| Dividend / Share(Rs.) |
2.50 |
2.00 |
2.00 |
2.00 |
2.00 |
|
| Revenue from Operations/Share (Rs.) |
237.89 |
223.44 |
227.94 |
286.90 |
216.73 |
|
| PBDIT/Share (Rs.) |
67.73 |
63.90 |
54.15 |
107.98 |
66.72 |
|
| PBIT/Share (Rs.) |
62.82 |
60.13 |
49.96 |
104.26 |
63.18 |
|
| PBT/Share (Rs.) |
54.39 |
64.44 |
43.19 |
90.47 |
61.90 |
|
| Net Profit/Share (Rs.) |
48.00 |
57.49 |
35.95 |
75.86 |
52.60 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
28.46 |
28.59 |
23.75 |
37.63 |
30.78 |
|
| PBIT Margin (%) |
26.40 |
26.91 |
21.91 |
36.34 |
29.15 |
|
| PBT Margin (%) |
22.86 |
28.83 |
18.94 |
31.53 |
28.56 |
|
| Net Profit Margin (%) |
20.17 |
25.72 |
15.77 |
26.44 |
24.27 |
|
| Return on Networth / Equity (%) |
10.24 |
13.58 |
9.76 |
22.68 |
20.15 |
|
| Return on Capital Employed (%) |
10.70 |
11.41 |
10.77 |
24.45 |
20.13 |
|
| Return on Assets (%) |
7.14 |
9.46 |
6.64 |
15.28 |
14.67 |
|
| Total Debt/Equity (X) |
0.27 |
0.26 |
0.29 |
0.29 |
0.11 |
|
| Asset Turnover Ratio (%) |
35.41 |
36.77 |
42.13 |
57.82 |
60.46 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.85 |
2.25 |
2.69 |
3.02 |
1.69 |
|
| Quick Ratio (X) |
1.50 |
1.85 |
2.18 |
2.44 |
1.33 |
|
| Inventory Turnover Ratio (X) |
8.02 |
6.92 |
5.79 |
7.07 |
6.32 |
|
| Dividend Payout Ratio (NP) (%) |
5.02 |
4.19 |
6.69 |
3.17 |
4.57 |
|
| Dividend Payout Ratio (CP) (%) |
4.55 |
3.93 |
5.99 |
3.02 |
4.28 |
|
| Earnings Retention Ratio (%) |
94.98 |
95.81 |
93.31 |
96.83 |
95.43 |
|
| Cash Earnings Retention Ratio (%) |
95.45 |
96.07 |
94.01 |
96.98 |
95.72 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
9,299.62 |
21,093.48 |
17,678.28 |
26,727.49 |
23,125.14 |
|
| EV/Net Operating Revenue (X) |
1.39 |
3.35 |
2.75 |
3.30 |
3.78 |
|
| EV/EBITDA (X) |
4.87 |
11.70 |
11.57 |
8.77 |
12.28 |
|
| MarketCap/Net Operating Revenue (X) |
0.87 |
2.89 |
2.31 |
2.99 |
3.66 |
|
| Retention Ratios (%) |
94.97 |
95.80 |
93.30 |
96.82 |
95.42 |
|
| Price/BV (X) |
0.44 |
1.53 |
1.43 |
2.56 |
3.04 |
|
| Price/Net Operating Revenue |
0.87 |
2.89 |
2.31 |
2.99 |
3.66 |
|
| Earnings Yield |
0.23 |
0.09 |
0.07 |
0.09 |
0.07 |
|
Source : Dion Global Solutions Limited
